EXCELLA - Trademark Details
Status: 700 - Registered
Serial Number
79245112
Registration Number
6374993
Word Mark
EXCELLA
Status
700 - Registered
Status Date
2021-06-08
Filing Date
2018-09-05
Registration Number
6374993
Registration Date
2021-06-08
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-09-03
Attorney Name
Law Office Assigned Location Code
N20
Employee Name
O'BRIEN, JENNIFER LYNN
Statements
Goods and Services
Food preservation services, namely, food and beverage preservation; preservation of medicines in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, namely, cryogenic preservation; pattern printing; Providing technical information in the field of the processing of food, drinks and medicines in the nature of providing technical information in the field of manufacturing active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection; treatment of gases, solids and liquids for packaging, bottling, bagging or packing thereof, namely, treatment of materials by means of laser beams, cryogenic processing, Fuel treatment services, Metal treatment, Nuclear waste treatment; treatment of mixtures of gases, solids and liquids for packaging, bottling, bagging, wrapping or conditioning thereof, namely, Treatment of materials by means of laser beams, cryogenic processing, Fuel treatment services, Metal treatment, Nuclear waste treatment; Decorative pattern printing on wrapping paper; printing of decorative patterns on paper packaging and plastic films; custom manufacture of pharmaceutical, cosmetic, industrial and household products, namely, custom manufacture of active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, chemotherapy drugs in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, antibiotic medicines in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection by pharmaceutical compounders and custom manufacture of furniture, containers, drapery; custom manufacture of fragrances; custom manufacture of medical devices for others, excluding medical devices containing pharmaceuticals that are in powder form reconstituted for injection or that are not in tablet form, not in capsule form, not in granule form, or not in pellet form; custom mold manufacturing services for use in industry; prototype manufacture of new third-party products for research and technical development of products, namely, prototype fabrication of new products for others, excluding products containing pharmaceuticals that are in powder form reconstituted for injection or that are not in tablet form, not in capsule form, not in granule form, or not in pellet form; custom manufacture of machines and tools for compressing and compacting powders and granules; application of thin films on object surfaces in the nature of treatment of materials by means of chemical, mechanical, thermal, thermomechanical processes, chemical vapor deposition, physical vapor deposition and vacuum deposition; application of coatings in the nature of treatment of materials by means of chemical, mechanical, thermal or thermo-mechanical processes; paper finishing; custom assembly of materials for others, namely, assembly of products for others, excluding products containing pharmaceuticals that are in powder form reconstituted for injection or that are not in tablet form, not in capsule form, not in granule form, or not in pellet form; custom assembly of composite and plastic parts for others; Providing information relating to the treatment of materials; custom perfume mixing services, namely, custom manufacture of perfume; treatment of hazardous liquids; treatment of materials upon third-party request by means of laser beams, cryogenic processing; treatment of biopharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection, active pharmaceutical ingredients, cosmetic materials and chemical materials by means of laser beams, cryogenic processing; treatment of medicinal materials in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection medicinal materials in the nature of active pharmaceutical ingredients, and cosmetic materials by means of laser beams, cryogenic processing; processing of chemicals; processing of chemical and petrochemical products, namely, processing of fuel materials, processing of oil, gas processing services; none of the foregoing related to pharmaceuticals in table form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection
Goods and Services
Industrial research, testing and analysis services in the field of physics, bacteriology; biological research services; medical research; biochemical research; biotechnological research services; cosmetic research services; engineering research services; mechanical research; technological research services in the field of medical instruments, video surveillance equipment; scientific research, development and analysis; technical research projects and studies in the field of home care, cosmetics, food; research in the field of hair care; research and development in the field of biotechnology; bacteriological research services; research, development and analysis services in the field of chemistry and biology; research in the field of environmental preservation; laboratory research and analysis services in the field of bacteriology, chemistry, cosmetics; preparation of reports relating to scientific research, namely, scientific study and research in the field(s) of medicine, the prevention, treatment and management of illness, health care delivery; preparation of reports relating to technical research, namely, technical research in the field of home care, cosmetics, food; preparation of reports relating to technological research, namely, technological research in the field of home care, cosmetics, food; services provided by consultants in the field of pharmaceuticals research, namely, research regarding active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection; services provided by consultants in the field of scientific research; services provided by consultants in the field of technological research in the field of aerospace engineering, geology; research and development services in the field of bacteriology; research and development services in the field of cytology; research and development services in connection with physics; scientific research, testing and analysis services in the field of home care, cosmetics, food; provision of technical advice in the field of scientific and industrial research in the field of home care, cosmetics, food; scientific research relating to hair care preparations; services provided by consultants relating to research and development in the field of therapeutics; provision of information about industrial analysis and research services in the field of home care, cosmetics, food; provision of information relating to medical and scientific research in the field of pharmaceutical products, namely, research regarding active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection; provision of information and data relating to medical and veterinary scientific research and development; provision of information and data relating to scientific and technological research and development in the field of home care, cosmetics, food; services provided by consultants and research in the field of engineering and information technology; services provided by consultants relating to research services in the field of foods and dietary supplements; none of the foregoing related to pharmaceuticals other than active pharmaceutical ingredients and pharmaceuticals in tablet form, capsule form, granule form, pellet form, and powder form that is not reconstituted for injection
Classification Information
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2018-11-09
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-11-09
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
30
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
30
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
30
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
30
Address
Please log in with your Justia account to see this address.
Correspondences
Name
THOMAS E ZUTIC
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1433583
International Registration Date
2018-09-05
International Publication Date
2018-11-08
International Renewal Date
2028-09-05
Auto Protection Date
2020-05-08
International Status
001 - Request for extension of protection established
International Status Date
2018-11-08
Priority Claimed In
True
Priority Claimed Date
2018-04-30
First Refusal In
True
Trademark Events
Event Date | Event Description |
2018-11-08 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2018-11-09 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-11-13 | APPLICATION FILING RECEIPT MAILED |
2018-12-15 | ASSIGNED TO EXAMINER |
2018-12-20 | NON-FINAL ACTION WRITTEN |
2018-12-21 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2019-01-08 | REFUSAL PROCESSED BY MPU |
2019-01-08 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2019-01-25 | REFUSAL PROCESSED BY IB |
2019-07-03 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2019-07-03 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2019-07-03 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-07-03 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-07-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-07-23 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-07-31 | ASSIGNED TO LIE |
2019-08-14 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-08-14 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2019-08-14 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2019-08-30 | NOTIFICATION PROCESSED BY IB |
2019-09-03 | PUBLISHED FOR OPPOSITION |
2019-09-03 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-10-02 | EXTENSION OF TIME TO OPPOSE RECEIVED |
2020-01-03 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
2020-01-03 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
2020-01-11 | OPPOSITION INSTITUTED NO. 999999 |
2020-01-31 | REFUSAL PROCESSED BY IB |
2020-04-08 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
2020-04-08 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2020-04-24 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
2021-03-26 | NEW REPRESENTATIVE AT IB RECEIVED |
2021-05-01 | OPPOSITION DISMISSED NO. 999999 |
2021-05-01 | OPPOSITION TERMINATED NO. 999999 |
2021-05-01 | TTAB RELEASE CASE TO TRADEMARKS |
2021-06-08 | REGISTERED-PRINCIPAL REGISTER |
2021-09-08 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2021-09-29 | FINAL DISPOSITION PROCESSED |
2021-09-29 | FINAL DISPOSITION NOTICE SENT TO IB |
2021-10-24 | FINAL DECISION TRANSACTION PROCESSED BY IB |